Adjunctive testing in the evaluation of adults after Kawasaki disease

Circ J. 2015;79(11):2299-305. doi: 10.1253/circj.CJ-15-0996. Epub 2015 Oct 15.

Abstract

Acute Kawasaki disease (KD) is diagnosed and treated by pediatricians, but decades later, these individuals are presenting to adult cardiologists with a variety of cardiovascular sequelae, including myocardial ischemia and infarction, congestive heart failure secondary to myocardial fibrosis, and claudication because of vascular insufficiency from thrombosed peripheral arteries. There are no clinical trials to guide management, interventions, and medical therapy in this patient population. This review summarizes the emerging information regarding evaluation of the cardiovascular status of adults decades after childhood KD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Diagnostic Techniques, Cardiovascular*
  • Disease Progression
  • Heart Diseases / diagnosis*
  • Heart Diseases / etiology
  • Heart Diseases / physiopathology
  • Humans
  • Mucocutaneous Lymph Node Syndrome / complications*
  • Mucocutaneous Lymph Node Syndrome / diagnosis
  • Peripheral Vascular Diseases / diagnosis*
  • Peripheral Vascular Diseases / etiology
  • Peripheral Vascular Diseases / physiopathology
  • Predictive Value of Tests
  • Prognosis